Piclib 125mg (Palbociclib)

Piclib 125mg (Palbociclib) is a kinase inhibitor used for treating advanced or metastatic breast cancer in women with hormone receptor-positive and HER2-negative tumors. It is prescribed in combination with either an aromatase inhibitor or fulvestrant, depending on the patient's history of endocrine therapy.

DOSAGE AND ADMINISTRATION

The recommended starting dose is 125mg taken orally once daily with food for 21 days followed by a 7-day treatment-free period. Dosing adjustments may be necessary based on individual safety and tolerability.

Palbociclib Cost in India:

Palbociclib price in India is only 6% of the cost in the United States. Generic Palbociclib is a prescription medicine that contains the same active ingredient and meets the same pharmaceutical standards as brand-name medicine.

Piclib 125mg (Palbociclib) Side Effects：

Palbociclib has some common side effects, including low white blood cell counts, low red blood cell counts, low platelet counts, fatigue, nausea, mouth sores, diarrhea, hair thinning or loss, vomiting, rash, loss of appetite, and abnormalities in liver blood tests. Low white blood cell counts can lead to serious infections, so it's essential to monitor blood cell counts regularly. If necessary, healthcare providers may interrupt treatment, reduce the dose, or delay the start of a new cycle. Palbociclib may also affect male fertility.

For more Prescribing information，please check the → “FDA Prescribing Information